Analysis of Common Mutations in the Galactose-1-Phosphate Uridyl Transferase Gene

Leslie, 1992, The human galactose-1-phosphate uridyl transferase gene, Genomics, 14, 474, 10.1016/S0888-7543(05)80244-7 Reichardt, 1998, Cloning and characterization of a cDNA encoding human galactose-1-phosphate uridyl transferase, Mol Biol Med, 5, 107 Levy, 1980, Screening for galactosemia, 133 Shih, 1971, Galactosemia screening in Massachusetts, N Engl J Med, 284, 753, 10.1056/NEJM197104082841404 Holton JB, Walter JH, Tyfield L: Galactosemia Scriver CR, Beaudet AL, Sly WS, Valle D. The Metabolic and Molecular Basis of Inherited Disease ed 8. McGraw-Hill New York, pp 1553–1587 Elsas Elsas, 1995, Galactosemia: a strategy to identify new biochemical phenotypes and molecular genotypes, Am J Hum Genet, 56, 630 Elsas, 1998, The molecular biology of galactosemia, Genet Med, 1, 40, 10.1097/00125817-199811000-00009 Lai, 1996, A prevalent mutation for galactosemia among black Americans, J Pediatr, 128, 89, 10.1016/S0022-3476(96)70432-8 Kozak, 1997, Molecular heterogeneity of classical and Duarte galactosemia: mutation analysis by denaturing gradient electrophoresis, Hum Mutat, 10, 49, 10.1002/(SICI)1098-1004(1997)10:1<49::AID-HUMU7>3.0.CO;2-H Lin, 1994, On the nature of the Duarte variant of galactose-1-phosphate uridyl transferase (GALT), Hum Genet, 93, 167, 10.1007/BF00210604 Elsas, 1994, A common mutation associated with the Duarte galactosemia allele, Am J Hum Genet, 54, 1030 Wittwer, 1991, Rapid cycle DNA amplification: time and temperature optimization, Biotechniques, 10, 76 Wittwer, 1997, The Light Cycler: a microvolume multisample fluorimeter with rapid temperature control, Biotechniques, 22, 176, 10.2144/97221pf02 Lay, 1997, Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR, Clin Chem, 43, 2262, 10.1093/clinchem/43.12.2262 Bernard, 1998, Integrated amplification and detection of the C677T point mutation in the methylenetetrahydrofolate reductase gene by fluorescence resonance energy transfer and probe melting curves, Anal Biochem, 255, 101, 10.1006/abio.1997.2427 Bernard, 1998, Homogeneous multiplex genotyping of hemochromatosis mutations with fluorescence probes, Am J Pathol, 153, 1055, 10.1016/S0002-9440(10)65650-7 Gundry, 1999, Rapid F508 del and F508C assay using fluorescent hybridization probes, Genet Test, 3, 365, 10.1089/gte.1999.3.365 von Ahsen, 1999, Rapid detection of prothrombic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence melting curves, Mol Diagn, 45, 694 Mangassner-Stephan, 1999, Rapid genotyping of hemochromatosis gene mutations on the Light Cycler with fluorescent hybridization probes, Clin Chem, 45, 1875, 10.1093/clinchem/45.10.1875 Aslanidis, 1999, High-speed apolipoprotein E genotyping and apolipoprotein B3500 mutation detection using real-time fluorescence PCR and melting curves, Clin Chem, 45, 1094, 10.1093/clinchem/45.7.1094 Dobrowolski, 1999, 115 Herrmann, 2000, Rapid b-globin genotyping by multiplex probe melting temperature and color, Clin Chem, 46, 425, 10.1093/clinchem/46.3.425 Heath, 1999, Optimization of an automated protocol to isolate DNA from Guthrie cards, Arch Pathol Lab Med, 123, 1154, 10.5858/1999-123-1154-OOAADP Pollitt, 1997, Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step, J Med Screening, 4, 23, 10.1177/096914139700400109 Ferec, 1999, Neonatal CF-screening: combined IRT and DNA-based techniques results of a 10-year program in Brittany, 185 Gregg, 1997, Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods, Pediatrics, 99, 819, 10.1542/peds.99.6.819 Spence, 1993, Neonatal screening for cystic fibrosis: addition of molecular diagnosis to increase specificity, Biochem Med Metab Biol, 49, 200, 10.1006/bmmb.1993.1022 Gregersen, 1991, Molecular characterization of medium-chain acyl-CoA dehydrogenase deficiency: identification of a lys329 to glu mutation in the MCAD gene and expression of mutant enzyme protein in E. coli, Hum Genet, 86, 545, 10.1007/BF00201539 Keegan, 2001, An overview of molecular diagnosis of steroid 21-hydroxylase deficiency, J Mol Diagn, 3, 49, 10.1016/S1525-1578(10)60651-4 Ijlst, 1996, Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, J Clin Invest, 98, 1028, 10.1172/JCI118863 Magdalena, 1999, Overview of mutations in the PCCA and PCCB genes causing propionic acidemia, Hum Mutat, 14, 275, 10.1002/(SICI)1098-1004(199910)14:4<275::AID-HUMU1>3.0.CO;2-N Descartes, 1991, Genotypic confirmation from the original dried blood specimen in a neonatal hemoglobinopathy screening program, Pediatr Res, 31, 217, 10.1203/00006450-199203000-00005 Pomponio, 1997, Mutations in the human biotinidase gene that cause profound biotinidase deficiency in symptomatic children: molecular, biochemical, and clinical analysis, Pediatr Res, 42, 840, 10.1203/00006450-199712000-00020 Chace, 2000, Mass spectrometry in the clinical laboratory, Chem Rev, 101, 445, 10.1021/cr990077+